Ouabain-insensitive acidification by dopamine in renal OK cells: primary control of the Na(+)/H(+) exchanger

Am J Physiol Regul Integr Comp Physiol. 2001 Jul;281(1):R10-8. doi: 10.1152/ajpregu.2001.281.1.R10.

Abstract

The present study was aimed at evaluating the role of D(1)- and D(2)-like receptors and investigating whether inhibition of Na(+) transepithelial flux by dopamine is primarily dependent on inhibition of the apical Na(+)/H(+) exchanger, inhibition of the basolateral Na(+)-K(+)-ATPase, or both. The data presented here show that opossum kidney cells are endowed with D(1)- and D(2)-like receptors, the activation of the former, but not the latter, accompanied by stimulation of adenylyl cyclase (EC(50) = 220 +/- 2 nM), marked intracellular acidification (IC(50) = 58 +/- 2 nM), and attenuation of amphotericin B-induced decreases in short-circuit current (28.6 +/- 4.5% reduction) without affecting intracellular pH recovery after CO(2) removal. These results agree with the view that dopamine, through the activation of D(1)- but not D(2)-like receptors, inhibits both the Na(+)/H(+) exchanger (0.001933 +/- 0.000121 vs. 0.000887 +/- 0.000073 pH unit/s) and Na(+)-K(+)-ATPase without interfering with the Na(+)-independent HCO transporter. It is concluded that dopamine, through the action of D(1)-like receptors, inhibits both the Na(+)/H(+) exchanger and Na(+)-K(+)-ATPase, but its marked acidifying effects result from inhibition of the Na(+)/H(+) exchanger only, without interfering with the Na(+)-independent HCO transporter and Na(+)-K(+)-ATPase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / analogs & derivatives*
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Acids / metabolism*
  • Animals
  • Bicarbonates / metabolism
  • Biological Transport / drug effects
  • Biological Transport / physiology
  • Cardiotonic Agents / pharmacology*
  • Cell Line
  • Cyclic AMP / metabolism
  • Dopamine / pharmacology*
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / pharmacology
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Hydrogen-Ion Concentration
  • Kidney Tubules, Proximal / cytology
  • Kidney Tubules, Proximal / metabolism*
  • Opossums
  • Ouabain / pharmacology*
  • Radioligand Assay
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / metabolism
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors
  • Sodium-Hydrogen Exchangers / metabolism*
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Tritium

Substances

  • Acids
  • Bicarbonates
  • Cardiotonic Agents
  • Dopamine Agonists
  • Dopamine Antagonists
  • Enzyme Inhibitors
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Sodium-Hydrogen Exchangers
  • Tritium
  • Ouabain
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • 1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-
  • Cyclic AMP
  • Sodium-Potassium-Exchanging ATPase
  • Dopamine